| Control | T2D | Sepsis | p Value |
---|---|---|---|---|
Number of subjects | 17 | 20 | 14 | – |
Male sex, % | 30 | 80 | 57 | 0.008a |
Age, yr | 56 ± 3b | 68 ± 1c | 69 ± 3c | <0.001 |
BMI, kg/m2 | 24.8 ± 1.0b | 28.9 ± 0.9c | 29.5 ± 1.2c | 0.003 |
HbA1c, % | 5.5 ± 0.1b | 7.8 ± 0.4c | 5.9 ± 0.3b | <0.001 |
HOMA-IR, AU | 1.5 ± 0.3b | 5.6 ± 1.4c | 4.3 ± 1.3c | 0.022 |
GFR, ml/min | 95.3 ± 3.0b | 70.8 ± 3.7c | 44.9 ± 10.5 | <0.001 |
CRP, mg/L | 3.5 ± 0.5b | 15.9 ± 9.5c | 220.5 ± 26.8d | <0.001 |
Malignancy, % | 65 | 80 | 64 | 0.736a |
Duration of ICU stay, days |  |  | 7.8 ± 2.1 | – |
ICU non-survivors, n |  |  | 5/14 | – |